Minjiang University,Chinaš
Dr. Xiaodong Xie is an esteemed Associate Professor at Minjiang University, where he also serves as the Director of the Fujian Society of Biomedical Engineering. His extensive research background includes pioneering work in pharmaceutical analysis, targeted drug delivery systems, and nanomedicine, with a specific focus on cancer metastasis prevention. Through his innovative research, Dr. Xie has contributed to more than 20 SCI-indexed publications, many in high-impact journals such as Nature Communications and Advanced Functional Materials. His work is recognized nationally, advancing biosafety standards and enhancing the therapeutic applications of biomaterials.
Professional ProfileĀ
Education š:
Dr. Xie completed his Ph.D. in Pharmaceutical Analysis from Fuzhou University, China, in 2020. His doctoral research focused on developing advanced analytical techniques to improve pharmaceutical quality and efficacy. This strong foundation has since been instrumental in his work on nanomedicine and biosafety in cancer research, reflecting a commitment to leveraging scientific rigor for tangible health benefits.
Work Experience š¼:
Currently an Associate Professor at Minjiang University in Fujian, China, Dr. Xie plays a critical role in the institutionās research initiatives, particularly in biomedical engineering and targeted drug delivery. His academic career is complemented by active collaboration with national research institutions, where he contributes to advancements in pharmaceutical and biomedical fields. His leadership and expertise in both education and research position him as a central figure in the application of biosafety protocols in medical innovation.
Skills š
Nanomedicine and Drug Delivery: He has developed targeted nanoparticle systems that advance drug delivery effectiveness and inhibit tumor metastasis, optimizing treatment specificity.Biomedical Engineering: Through his expertise, Dr. Xie has engineered innovative biomaterials with applications in therapeutic and diagnostic medicine.Cancer Metastasis Research: His research involves using molecular targeting techniques to prevent the spread of cancer, contributing to cancer metastasis chemoprevention.
Awards and Honors š
Dr. Xieās contributions to the field are frequently recognized through his publications in influential journals, including Nature Communications and Advanced Functional Materials. His research on cancer prevention and nanomedicine has garnered significant recognition, establishing him as a key contributor to biomedical research and pharmaceutical sciences.
Memberships š¤
As the Director of the Fujian Society of Biomedical Engineering, Dr. Xie actively participates in advancing biomedical engineering research and promoting high standards within the field. His membership and leadership in this society underscore his dedication to biomedical innovation and his influence in shaping industry practices and standards.
Teaching Experience š©āš«:
Dr. Xie is a passionate educator who mentors students in biomedical engineering and pharmaceutical sciences. He has developed comprehensive research-oriented programs to engage students in hands-on, practical applications of biosafety and drug delivery. Dr. Xie fosters a research-driven educational environment that encourages students to pursue innovative solutions in the fields of nanomedicine and biomaterials.
Research Focus š¬:
Dr. Xieās research centers on creating advanced biomedical solutions that enhance drug delivery systems and biosafety protocols, particularly for cancer treatment. His projects include developing nanomolecular imaging probes to support individualized cancer treatment and investigating the molecular mechanisms to prevent tumor metastasis. His work exemplifies a forward-thinking approach to medical challenges, aiming to improve patient outcomes and expand the potential of therapeutic applications in cancer research.
š PublilcationĀ
- “Poly (heptazine imide) nanocrystal for hydrogen peroxide evolution in the dark by accumulating photo-generated electrons”
- Year: 2024
- Journal: Nano Research
- “Multi-targeted nanoarrays for early broad-spectrum detection of lung cancer based on blood biopsy of tumor exosomes”
- Year: 2024
- Journal: Talanta
- “Enhancing glioma-specific drug delivery through self-assembly of macrophage membrane and targeted polymer assisted by low-frequency ultrasound irradiation”
- Year: 2024
- Journal: Materials Today Bio
- “Ganoderma lucidum spore oil synergistically enhances the function of cyclophosphamide in the prevention of breast cancer metastasis”
- Year: 2024
- Journal: Journal of the Chinese Medical Association
- “Effects of GanoExtra combined with CTX on lung metastasis and immune function in mice”
- Year: 2024
- Journal: Chinese Pharmacological Bulletin
- “Cancer metastasis chemoprevention prevents circulating tumour cells from germination”
- Year: 2022
- Journal: Signal Transduction and Targeted Therapy
- “Interleukin-10 plasmid delivery by polymeric nanocarrier shows efficient and safe tissue repair in acute muscle damage models in mice”
- Year: 2022
- Journal: Nano Today
- “Fucoxanthin prevents breast cancer metastasis by interrupting circulating tumor cells adhesion and transendothelial migration”
- Year: 2022
- Journal: Frontiers in Pharmacology
- “Use of Nanoformulation to Target Macrophages for Disease Treatment”
- Year: 2021
- Journal: Advanced Functional Materials
- “Tumor-derived exosomes can specifically prevent cancer metastatic organotropism”
- Year: 2021
- Journal: Journal of Controlled Release
Let me know if you need further information or details on each publication!